医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

KBRA Releases Comment on the Coronavirus and its Effect on the Commercial Aviation Industry

2020年02月01日 AM07:02
このエントリーをはてなブックマークに追加


 

NEW YORK

Kroll Bond Rating Agency (KBRA) releases a comment on the Wuhan coronavirus outbreak in China and beyond, and its potential impact on the airline industry.

The commercial airline industry is cyclical and continually faces many challenges including volatile oil prices, weak economic conditions, labor issues, and competition. However, the industry is also vulnerable to event risks such as terrorism, pandemics, political instability, and natural disasters—all of which could curtail passenger travel in a very short time following a major event.

KBRA notes that while external shocks are often followed by a decline in passenger travel, such drops have been temporary and passenger growth has rebounded quickly. That said, the impact on revenues for affected airlines, while temporary, has in most cases led to consequences for these airlines’ credit profiles and access to capital markets—even if in the short term. Further, airlines globally are at risk of a change in consumer travel behavior as a result of the coronavirus.

To access the comment, click here.

CONNECT WITH KBRA

Twitter
LinkedIn
YouTube

About KBRA and KBRA Europe

KBRA is a full-service credit rating agency registered with the U.S. Securities and Exchange Commission as an NRSRO. In addition, KBRA is designated as a designated rating organization by the Ontario Securities Commission for issuers of asset-backed securities to file a short form prospectus or shelf prospectus. KBRA is also recognized by the National Association of Insurance Commissioners as a Credit Rating Provider and is a certified Credit Rating Agency (CRA) by the European Securities and Markets Authority (ESMA). Kroll Bond Rating Agency Europe Limited is registered with ESMA as a CRA.

View source version on businesswire.com: https://www.businesswire.com/news/home/20200131005592/en/

CONTACT

Analytical:

Thomas Moore, Senior Analyst

(646) 731-3375

tmoore@kbra.com

Marjan Riggi, Senior Managing Director

(646) 731-2354

mriggi@kbra.com

Business Development:

Nish Kumar, Senior Director

(646) 731-3372

nkumar@kbra.com

Related Posts Plugin for WordPress, Blogger...

同じカテゴリーの記事 

  • Seoul Viosys’ Violeds Modules Proven to Disinfect 99% of Airborne Viruses in a Recent Testing Result
  • Kaye推出适用于冷链运输市场的Kaye® Log -80℃ 疫苗温度记录器,以满足COVID-19疫苗储存和运输的要求
  • Kaye® (ケイ)は、COVID-19ワクチンの輸送・保管のニーズに応えるためにKaye® ログ -80ワクチン温度ロガーを、コールドチェーン市場向けに導入(発売)します。
  • Aurinia Announces Collaboration and Licensing Agreement with Otsuka Pharmaceutical Co., Ltd. for the Development and Commercialization of Voclosporin in Europe and Japan
  • DNP的新型非接触式透明屏幕可通过手的动作进行操作